Related Experiment Videos
Recurrence-associated mortality in patients with differentiated thyroid carcinoma
1Department of Nuclear Medicine, Hadassah University Hospital, Jerusalem, Israel.
Journal of Surgical Oncology
|March 1, 1993
Summary
Age over 40 at initial diagnosis is a key predictor of mortality in differentiated thyroid carcinoma (DTC) patients with recurrent disease. This finding aids in identifying high-risk DTC patients for targeted interventions.
Area of Science:
- Oncology
- Endocrinology
Background:
- Differentiated thyroid carcinoma (DTC) has a prolonged course, making prognosis assessment challenging.
- Recurrence does not always correlate with increased mortality, complicating treatment strategy evaluation.
Purpose of the Study:
- To identify prognostic factors for mortality in patients with recurrent DTC.
- To predict which patients are at higher risk of dying from DTC.
Main Methods:
- Retrospective analysis of 157 DTC patients.
- Evaluation of risk factors in 36 patients with recurrent disease.
Main Results:
- Age over 40 at initial diagnosis was the primary risk factor for mortality (44% mortality).
- Male sex, no radioiodine treatment, and distant recurrence showed trends towards increased mortality.
- Tumor histology and initial treatment extent did not significantly impact mortality.
Conclusions:
- Age at diagnosis is a significant predictor of mortality in recurrent DTC.
- This risk stratification can identify high-risk patients, potentially guiding future treatment development.
- Further research is needed to improve treatment protocols for high-risk DTC patients.